Beximco Pharmaceuticals PLC. (BST:R2WA)
Germany
· Delayed Price · Currency is EUR 0.458
+0.008 (1.78%)
At close: Dec 5, 2025
BST:R2WA Ratios and Metrics
Market cap in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Market Capitalization | 345 | 418 | 550 | 706 | 786 | 294 | Upgrade
|
| Market Cap Growth | 35.73% | -23.94% | -22.07% | -10.21% | 167.81% | -16.61% | Upgrade
|
| Enterprise Value | 396 | 495 | 669 | 861 | 868 | 406 | Upgrade
|
| Last Close Price | 0.46 | 0.42 | 0.37 | 0.99 | 0.87 | 0.31 | Upgrade
|
| PE Ratio | 6.73 | 9.04 | 14.14 | 13.46 | 15.43 | 7.99 | Upgrade
|
| PS Ratio | 0.92 | 1.19 | 1.66 | 1.99 | 2.68 | 1.10 | Upgrade
|
| PB Ratio | 0.80 | 1.01 | 1.37 | 1.55 | 2.12 | 0.86 | Upgrade
|
| P/TBV Ratio | 0.97 | 1.24 | 1.70 | 1.96 | 2.25 | 0.92 | Upgrade
|
| P/FCF Ratio | 10.45 | 8.27 | 17.75 | 28.75 | 22.58 | 8.51 | Upgrade
|
| P/OCF Ratio | 6.45 | 6.30 | 10.72 | 13.23 | 13.13 | 5.06 | Upgrade
|
| EV/Sales Ratio | 1.22 | 1.40 | 2.02 | 2.43 | 2.96 | 1.52 | Upgrade
|
| EV/EBITDA Ratio | 5.33 | 6.25 | 8.84 | 10.20 | 11.70 | 5.98 | Upgrade
|
| EV/EBIT Ratio | 6.42 | 7.52 | 11.48 | 12.78 | 13.75 | 7.22 | Upgrade
|
| EV/FCF Ratio | 12.00 | 9.78 | 21.57 | 35.06 | 24.92 | 11.76 | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.12 | 0.22 | 0.28 | 0.20 | 0.32 | Upgrade
|
| Debt / EBITDA Ratio | 0.58 | 0.60 | 1.18 | 1.50 | 1.02 | 1.62 | Upgrade
|
| Debt / FCF Ratio | 1.51 | 0.95 | 2.89 | 5.16 | 2.18 | 3.18 | Upgrade
|
| Asset Turnover | 0.64 | 0.64 | 0.58 | 0.59 | 0.58 | 0.52 | Upgrade
|
| Inventory Turnover | 1.77 | 1.87 | 1.77 | 1.91 | 2.03 | 1.91 | Upgrade
|
| Quick Ratio | 0.60 | 0.52 | 0.37 | 0.35 | 0.39 | 0.35 | Upgrade
|
| Current Ratio | 2.13 | 2.18 | 1.57 | 1.45 | 1.47 | 1.15 | Upgrade
|
| Return on Equity (ROE) | 12.45% | 11.79% | 9.81% | 12.19% | 14.72% | 11.31% | Upgrade
|
| Return on Assets (ROA) | 7.62% | 7.48% | 6.38% | 6.95% | 7.75% | 6.76% | Upgrade
|
| Return on Capital (ROIC) | 9.45% | 8.92% | 7.49% | 8.06% | 8.98% | 7.75% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.10% | 13.90% | 12.30% | 12.30% | 14.80% | 13.90% | Upgrade
|
| Earnings Yield | 14.85% | 11.06% | 7.07% | 7.43% | 6.48% | 12.52% | Upgrade
|
| FCF Yield | 9.57% | 12.09% | 5.63% | 3.48% | 4.43% | 11.76% | Upgrade
|
| Dividend Yield | 5.45% | 7.60% | 7.89% | 3.62% | 4.02% | 4.61% | Upgrade
|
| Payout Ratio | 21.72% | 27.21% | 33.98% | 31.68% | 11.28% | 17.13% | Upgrade
|
| Total Shareholder Return | 5.54% | 7.60% | 7.89% | 3.62% | 4.02% | 4.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.